MedTrace Logo

WIBOFA - Validation of SCT02 With ECG-App for Detection of AF

NCT06351761 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 373

Last updated 2026-02-18

No results posted yet for this study

Summary

The aim of the study is to evaluate the performance of Withings SCT02 with embedded Withings ECG-app in the automatic detection of atrial fibrillation

Conditions

Interventions

DEVICE

Investigational Device (Withings SCT02) 30 second Electrocardiogram recording

30 second ECG recording with investigational device (Withings SCT02)

DEVICE

Reference Device (Schiller Cardiovit FT-1) 30 second Electrocardiogram recording

30 second ECG recording with reference device (Schiller Cardiovit FT-1)

Sponsors & Collaborators

  • Withings

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-03
Primary Completion
2025-06-10
Completion
2025-11-26
FDA Device
Yes

Countries

  • United States
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06351761 on ClinicalTrials.gov